Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry (ABPI) is the peak drug industry lobby group in the UK.
- Vincent Lawton - former president
- Trevor Jones - former Director General
Selling A Voluntary Code
Following widespread criticism of the UK drug industry in 2005 ABPI launched a revised version of its voluntary code of practice on marketing practices to take effect on January 1, 2006. In January 2006 PR Week reported that ABPI had hired Santé Communications to "handle a 'multi-faceted' campaign targeting all industry stakeholders from April." [1]
Santé MD Liz Shanahan told PR Week "The industry is often perceived by media and clinical communities to be an aggressive oligarch; in our experience that is not the case." [2]
PR Week reported that ABPI "continues to use Weber Shandwick and Consolidated Communications for PA in continental Europe and the UK respectively. It also uses other agencies on projects." [3]
Personnel
Other SourceWatch Resources
- Drug industry
- Prescription Medicine Code of Practice Authority
- Chris Brinsmead - former president
External links
- Ian Hall, "ABPI calls in Santé to promote ‘strict’ code", PR Week, January 19, 2006. (Sub req'd).
- David Quainton, "New code of honour", PR Week, March 9 2006. (Sub req'd)
- "ABPI code of practice arm fills comms post", PR Week, July 6, 2006. (Sub req'd)
| This article is a stub. You can help by expanding it. |
